Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
Earnings for Alkem Laboratories Limited (ALKEM.NS)
Earnings in 2023 (TTM): $239.73 M
According to Alkem Laboratories Limited's latest financial reports the company's current earnings (TTM) are $239.73 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Alkem Laboratories Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $239.73 M | $212.79 M |
| 2022 | $154.61 M | $116.62 M |
| 2021 | $218.54 M | $195 M |
| 2020 | $218.28 M | $187.82 M |
| 2019 | $149.28 M | $133.55 M |
| 2018 | $113.12 M | $90.12 M |
| 2017 | $109.72 M | $74.76 M |
| 2016 | $114.3 M | $105.7 M |
| 2015 | $100.14 M | $79.76 M |
| 2014 | $53.42 M | $46.4 M |
| 2013 | $53.93 M | $52.62 M |
| 2012 | $60.42 M | $58.79 M |
| 2011 | $53.84 M | $50.42 M |
| 2010 | $42.09 M | $39.11 M |
| 2009 | $29.04 M | $27.85 M |